ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SGMO Sangamo Therapeutics Inc

0.5055
-0.0105 (-2.03%)
Last Updated: 12:37:13
Delayed by 15 minutes

Period:

Draw Mode:

Volume 892,503
Bid Price 0.5021
Ask Price 0.5089
News -
Day High 0.5299

Low
0.2911

52 Week Range

High
1.78

Day Low 0.495
Company Name Stock Ticker Symbol Market Type
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0105 -2.03% 0.5055 12:37:13
Open Price Low Price High Price Close Price Prev Close
0.5172 0.495 0.5299 0.516
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,133 892,503 $ 0.5126761 $ 457,565 - 0.2911 - 1.78
Last Trade Time Type Quantity Stock Price Currency
12:37:52 11 $ 0.5055 USD

Sangamo Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
91.24M 178.91M - 176.23M -257.83M -1.44 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sangamo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SGMO Message Board. Create One! See More Posts on SGMO Message Board See More Message Board Posts

Historical SGMO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.52120.57470.4950.54233281,586,926-0.0157-3.01%
1 Month0.840.97820.4950.6272482,105,632-0.3345-39.82%
3 Months0.44891.480.4110.84716242,486,8720.056612.61%
6 Months0.57931.480.29110.67300272,032,593-0.0738-12.74%
1 Year1.761.780.29110.89134042,101,299-1.25-71.28%
3 Years11.3012.82970.29113.641,635,128-10.79-95.53%
5 Years11.6719.430.29116.561,703,312-11.16-95.67%

Sangamo Therapeutics Description

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Your Recent History

Delayed Upgrade Clock